Showing results (11-20 of 242) with videos related to

Sort By:
Pageof 25
Cancer Treatment and Research Communications|January 6, 2022
Pregnancy induced hyperplasia of residual breast tissue following risk reducing contralateral mastectomy - simply interesting or a clinically important observationOmali Pitiyarachchi, Kelly-Anne Phillips, Michael Friedlander
Gynecologic Oncology|March 11, 2014
"Platinum resistant" ovarian cancer: what is it, who to treat and how to measure benefit?Alison Davis, Anna V Tinker, Michael Friedlander
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 5, 2025
Cancer of the ovary, fallopian tube, and peritoneum: 2025 updateMalte Renz, Michael Friedlander, Jonathan S Berek
Journal of Gynecologic Oncology|July 20, 2018
A practical guide to understanding, using and including patient reported outcomes in clinical trials in ovarian cancerMichelle K Wilson, Rebecca Mercieca-Bebber, Michael Friedlander
Breast Cancer Research and Treatment|April 25, 2009
The fertility-related concerns, needs and preferences of younger women with breast cancer: a systematic reviewMichelle Peate, Bettina Meiser, Martha Hickey, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 7, 2023
Managing Adverse Effects Associated With Poly (ADP-ribose) Polymerase Inhibitors in Ovarian Cancer: A Synthesis of Clinical Trial and Real-World DataMichael Friedlander, Yeh Chen Lee, William P Tew
Current Oncology Reports|October 8, 2013
Hormonal treatment in recurrent and metastatic gynaecological cancers: a review of the current literatureDirkje W Sommeijer, Katrin M Sjoquist, Michael Friedlander
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 28, 2006
Paraneoplastic mononeuritis multiplex in non-small-cell lung carcinomaAnnabel C Martin, Michael Friedlander, Matthew C Kiernan
Asia-Pacific Journal of Clinical Oncology|November 28, 2018
Practical considerations for clinicians for transitioning patients on maintenance therapy with olaparib capsules to the tablet formulation of olaparibMichael Friedlander, Catherine Shannon, Jeffrey Goh, et al.
Pageof 25